期刊
SCIENTIFIC REPORTS
卷 4, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/srep07355
关键词
-
资金
- Project Future of Relay For Life Japan - Tokushima Breast Care Clinic
- MEXT KAKENHI Grant [251347212, 25293079, 26461948]
- IMSUT Joint Research Project
- Grants-in-Aid for Scientific Research [25293079, 26461948, 221S0001, 26350974] Funding Source: KAKEN
Xanthohumol (XN) is a natural anticancer compound that inhibits the proliferation of oestrogen receptor-alpha (ER alpha)-positive breast cancer cells. However, the precise mechanism of the antitumour effects of XN on oestrogen (E2)-dependent cell growth, and especially its direct target molecule(s), remain(s) largely unknown. Here, we focus on whether XN directly binds to the tumour suppressor protein prohibitin 2 (PHB2), forming a novel natural antitumour compound targeting the BIG3-PHB2 complex and acting as a pivotal modulator of E2/ER alpha signalling in breast cancer cells. XN treatment effectively prevented the BIG3-PHB2 interaction, thereby releasing PHB2 to directly bind to both nuclear-and cytoplasmic ER alpha. This event led to the complete suppression of the E2-signalling pathways and ER alpha-positive breast cancer cell growth both in vitro and in vivo, but did not suppress the growth of normal mammary epithelial cells. Our findings suggest that XN may be a promising natural compound to suppress the growth of luminal-type breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据